Clene (CLNN) Common Equity (2019 - 2026)
Clene (CLNN) posted Common Equity of -$24.8 million for Q2 2026, down 40.84% on a QoQ basis from -$17.6 million in Q4 2025, and down 189.79% year-over-year from $27.6 million in Q2 2025.
Analysis
Clene (CLNN) Common Equity (2019 - 2026) Analysis & Trends
Clene has reported Common Equity for 8 years, with the latest figure at -$24.8 million in Q2 2026.
- On a quarterly basis, Common Equity fell 189.79% year-over-year to -$24.8 million in Q2 2026; TTM through Jun 2026 was -$24.8 million, a 189.79% decrease from a year earlier, with the FY2025 full-year figure at -$17.6 million, down 98.62% from the prior year.
- Common Equity was -$24.8 million for Q2 2026 at Clene, down from -$17.6 million in the prior quarter.
- The five-year high for Common Equity was $21.5 million in Q2 2023, with the low at -$24.8 million in Q2 2026.
- Average Common Equity over 5 years is -$1.6 million, with a median of -$1.6 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2025: Common Equity jumped 3923.62% in 2023, then tumbled 1596.43% in 2025.
- Over 5 years, Common Equity stood at $3.2 million in 2022, then surged by 313.65% to $13.4 million in 2023, then plunged by 166.15% to -$8.9 million in 2024, then sank by 98.62% to -$17.6 million in 2025, then sank by 40.84% to -$24.8 million in 2026.
- The last three Common Equity figures came in at -$24.8 million (Q2 2026), -$17.6 million (Q4 2025), and -$12.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 106.07 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 85.49 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 80.86 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 2.61 Bn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 6.34 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 6.40 Bn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | -24.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.78 Mn |
| Dec 31, 2025 | -17.59 Mn |
| Sep 30, 2025 | -12.36 Mn |
| Jun 30, 2025 | -8.55 Mn |
| Mar 31, 2025 | -4.97 Mn |
| Dec 31, 2024 | -8.86 Mn |
| Sep 30, 2024 | -4.13 Mn |
| Jun 30, 2024 | -504,000.00 |
| Mar 31, 2024 | 4.26 Mn |
| Dec 31, 2023 | 13.39 Mn |
| Sep 30, 2023 | 21.40 Mn |
| Jun 30, 2023 | 21.53 Mn |
| Mar 31, 2023 | -1.63 Mn |
| Dec 31, 2022 | 3.24 Mn |
| Sep 30, 2022 | -9.32 Mn |
| Jun 30, 2022 | -563,000.00 |
| Mar 31, 2022 | 2.02 Mn |
| Dec 31, 2021 | 12.60 Mn |
| Sep 30, 2021 | 5.69 Mn |
| Jun 30, 2021 | -25.93 Mn |